ONCO PE Ratio & Valuation,Is ONCO Overvalued

ONCO Relative Valuation

ONCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ONCO is overvalued; if below, it's undervalued.

Historical Valuation

Onconetix Inc (ONCO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.39. The fair price of Onconetix Inc (ONCO) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：1.97

Fair

-0.00

-0.08

EV/EBITDA

Onconetix Inc. (ONCO) has a current EV/EBITDA of -0.08. The 5-year average EV/EBITDA is -2.44. The thresholds are as follows: Strongly Undervalued below -21.53, Undervalued between -21.53 and -11.98, Fairly Valued between 7.11 and -11.98, Overvalued between 7.11 and 16.66, and Strongly Overvalued above 16.66. The current Forward EV/EBITDA of -0.08 falls within the Historic Trend Line -Fairly Valued range.

-0.12

EV/EBIT

Onconetix Inc. (ONCO) has a current EV/EBIT of -0.12. The 5-year average EV/EBIT is -2.16. The thresholds are as follows: Strongly Undervalued below -17.65, Undervalued between -17.65 and -9.90, Fairly Valued between 5.59 and -9.90, Overvalued between 5.59 and 13.33, and Strongly Overvalued above 13.33. The current Forward EV/EBIT of -0.12 falls within the Historic Trend Line -Fairly Valued range.

0.00

Onconetix Inc. (ONCO) has a current PS of 0.00. The 5-year average PS is 10.56. The thresholds are as follows: Strongly Undervalued below -70.37, Undervalued between -70.37 and -29.90, Fairly Valued between 51.03 and -29.90, Overvalued between 51.03 and 91.49, and Strongly Overvalued above 91.49. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-0.12

P/OCF

Onconetix Inc. (ONCO) has a current P/OCF of -0.12. The 5-year average P/OCF is -3.21. The thresholds are as follows: Strongly Undervalued below -27.11, Undervalued between -27.11 and -15.16, Fairly Valued between 8.74 and -15.16, Overvalued between 8.74 and 20.69, and Strongly Overvalued above 20.69. The current Forward P/OCF of -0.12 falls within the Historic Trend Line -Fairly Valued range.

-0.12

P/FCF

Onconetix Inc. (ONCO) has a current P/FCF of -0.12. The 5-year average P/FCF is -2.85. The thresholds are as follows: Strongly Undervalued below -23.63, Undervalued between -23.63 and -13.24, Fairly Valued between 7.54 and -13.24, Overvalued between 7.54 and 17.94, and Strongly Overvalued above 17.94. The current Forward P/FCF of -0.12 falls within the Historic Trend Line -Fairly Valued range.

Onconetix Inc (ONCO) has a current Price-to-Book (P/B) ratio of 0.91. Compared to its 3-year average P/B ratio of 0.37 , the current P/B ratio is approximately 143.76% higher. Relative to its 5-year average P/B ratio of 4.31, the current P/B ratio is about -78.98% higher. Onconetix Inc (ONCO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -447.40%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -352.90% , the current FCF yield is about -100.00% lower.

0.90

P/B

Median3y

0.37

Median5y

4.31

-244.24

FCF Yield

Median3y

-447.40

Median5y

-352.90

Competitors Valuation Multiple

The average P/S ratio for ONCO's competitors is 0.00, providing a benchmark for relative valuation. Onconetix Inc Corp (ONCO) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of -25.37%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of ONCO decreased by 96.39% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -940.72 to -2.89K.

The secondary factor is the Revenue Growth, contributed -25.37%to the performance.

Overall, the performance of ONCO in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-25.37%

406.86K → 303.65K

Revenue Growth

207.50%

-940.72 → -2.89K

Margin Expansion

-278.52%

0.01 → -0.02

P/E Change

-96.39%

53.55 → 1.94

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Onconetix Inc (ONCO) currently overvalued or undervalued?

What is Onconetix Inc (ONCO) fair value?

ONCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Onconetix Inc (ONCO) is between to according to relative valuation methord.

How does ONCO's valuation metrics compare to the industry average?

What is the current P/B ratio for Onconetix Inc (ONCO) as of Dec 17 2025?

As of Dec 17 2025, Onconetix Inc (ONCO) has a P/B ratio of 0.91. This indicates that the market values ONCO at 0.91 times its book value.

What is the current FCF Yield for Onconetix Inc (ONCO) as of Dec 17 2025?

As of Dec 17 2025, Onconetix Inc (ONCO) has a FCF Yield of 0.00%. This means that for every dollar of Onconetix Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Onconetix Inc (ONCO) as of Dec 17 2025?

As of Dec 17 2025, Onconetix Inc (ONCO) has a Forward P/E ratio of -0.00. This means the market is willing to pay $-0.00 for every dollar of Onconetix Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Onconetix Inc (ONCO) as of Dec 17 2025?

As of Dec 17 2025, Onconetix Inc (ONCO) has a Forward P/S ratio of 0.00. This means the market is valuing ONCO at $0.00 for every dollar of expected revenue over the next 12 months.

ONCO Valuation

ONCO Valuation

ONCO Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Onconetix Inc (ONCO) currently overvalued or undervalued?

What is Onconetix Inc (ONCO) fair value?

How does ONCO's valuation metrics compare to the industry average?

What is the current P/B ratio for Onconetix Inc (ONCO) as of Dec 17 2025?

What is the current FCF Yield for Onconetix Inc (ONCO) as of Dec 17 2025?

What is the current Forward P/E ratio for Onconetix Inc (ONCO) as of Dec 17 2025?

What is the current Forward P/S ratio for Onconetix Inc (ONCO) as of Dec 17 2025?